ArticleEndocrine2020
Use of the Thyroid Imaging Reporting and Data System (TIRADS) in clinical practice: an Italian survey.
Article in Endocrine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Article
- Assessment of thyroid nodule risk stratification knowledge and utilization among Polish physicians: a pilot study.Polish journal of radiology · 2024Article
- Article
- The European Institute of Oncology Thyroid Imaging Reporting and Data System for Classification of Thyroid Nodules: A Prospective Study.Journal of clinical medicine · 2022Article
- Evaluation of the efficacy of EU-TIRADS and ACR-TIRADS in risk stratification of pediatric patients with thyroid nodules.Frontiers in endocrinology · 2022Article
- Benefits of Contrast-Enhanced Ultrasonography to the Differential Diagnosis of TI-RADS 4-5 Thyroid Nodules.Applied bionics and biomechanics · 2022Article
- The impact of TI-RADS in detecting thyroid malignancies: a prospective study.La Radiologia medica · 2021Article
- Thyroid Nodule Characterization: How to Assess the Malignancy Risk. Update of the Literature.Diagnostics (Basel, Switzerland) · 2021Review
- Contemporary Thyroid Nodule Evaluation and Management.The Journal of clinical endocrinology and metabolism · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo perform an online survey about the use of Thyroid Imaging Reporting and Data System (TIRADS) classification in Italy.
methodsAn online questionnaire was administered to all members of the Italian Society of Medical and Interventional Radiology (Società Italiana di Radiologia Medica ed Interventistica, SIRM) and Italian Society of Ultrasound in Medicine and Biology (Società Italiana di Ultrasonologia in Medicina e Biologia, SIUMB). The survey consisted of 14 questions about demographics, knowledge, and the use of TIRADS classification, current job, expertize in thyroid ultrasound and fine needle aspiration biopsy, and work environment. Descriptive and nonparametric statistics were used, with P < 0.05 indicating statistical significance.
resultsA total of 1544 answers (9.8% out of 15,836) were received. The participants were 45 (36-59) years old [median (25th-75th percentiles)] and mostly (53.6%) familiar with TIRADS classification. Structured reporting (P < 0.001), expertize in thyroid ultrasound (P = 0.005) and fine needle aspiration biopsy (P < 0.001), and work in a multidisciplinary team (P < 0.001) were associated with the use of TIRADS classification. Physicians working in other fields than radiology were more prone to using TIRADS classification than radiologists and radiologists-in-training (P < 0.001).
conclusionMost physicians adopt TIRADS classification when performing thyroid ultrasound. TIRADS classification provides recommendations for the management of thyroid nodules and its use has to be encouraged.
Indexed as
Identifiers
31983030What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.